Are TNF inhibitors still the agent of choice for RA?

被引：0
|
作者：
Taylor, Peter C. [1 ]
机构：
[1] Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskeleta, Oxford, England
来源：
NATURE REVIEWS RHEUMATOLOGY | 2023年
关键词：
RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; METHOTREXATE; COMBINATION; ADALIMUMAB;
D O I：
10.1038/s41584-023-01043
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Since entering the clinic 25 years ago, biologic TNF inhibitors have transformed the outlook for people with rheumatoid arthritis and set the standard for all other targeted therapies. Despite changes to the therapeutic landscape, TNF inhibitors look set to remain an important treatment option for the foreseeable future.
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Are TNF inhibitors still the agent of choice for RA?
    Taylor, Peter C.
    NATURE REVIEWS RHEUMATOLOGY, 2023, 19 (12) : 755 - 756
  • [2] Methotrexate: Still the anchor drug in RA treatment
    Bijlsma, Johannes W. J.
    Jacobs, Johannes W. G.
    JOINT BONE SPINE, 2009, 76 (05) : 452 - 454
  • [3] Guidelines in RA treatment: concepts on safety and recomendations using anti-TNF-α inhibitors
    Diaz-Jouanen, Efrain
    Abud-Mendoza, Carlos
    Alberto Garza-Elizondo, Mario
    Medrano-Ramirez, Gabriel
    Burgos-Vargas, Ruben
    Javier Orozco-Alcala, Jose
    Francisco Pacheco-Tena, Cesar
    Pineda, Carlos
    Pozos-Espindola, Juan Carlos
    Ramos-Niembro, Francisco
    Robles-San-Roman, Manuel
    Ernesto Santana-Sahagun, Jesus
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2009, 61 (03): : 252 - 266
  • [4] Adverse effects of TNF inhibitors in SpA: Are they different from RA?
    Sampaio-Barros, Percival D.
    van der Horst-Bruinsma, Irene E.
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2014, 28 (05): : 747 - 763
  • [5] RHEUMATOID ARTHRITIS TNF inhibitors and cardiovascular risk management in RA
    Pope, Janet E.
    NATURE REVIEWS RHEUMATOLOGY, 2016, 12 (06) : 317 - U17
  • [6] Intensive treatment and treatment holiday of TNF-inhibitors in rheumatoid arthritis
    Tanaka, Yoshiya
    CURRENT OPINION IN RHEUMATOLOGY, 2012, 24 (03) : 319 - 326
  • [7] The Role of TNF Inhibitors in Psoriatic Disease
    Mandell, Brian F.
    Sobell, Jeffrey M.
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2014, 33 : S64 - S68
  • [8] Cardiovascular safety of the class of JAK inhibitors or tocilizumab compared with TNF inhibitors in patients with rheumatoid arthritis: Systematic review and a traditional and Bayesian network meta-analysis of randomized clinical trials
    Pugliesi, Alisson
    Chicre Oliveira, Daniela Gomes
    de Souza Filho, Vani Abreu
    Machado, Julia de Oliveira
    Pereira, Aline Gonsalves
    Silveira Bichuette, Julia de Castro
    Sachetto, Zoraida
    de Carvalho, Luiz Sergio F.
    Bertolo, Manoel Barros
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 69
  • [9] Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors, tocilizumab, or abatacept in osteoporosis with rheumatoid arthritis
    Suzuki, Takako
    Nakamura, Yukio
    Kato, Hiroyuki
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 : 453 - 459
  • [10] Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis
    Taylor, Peter C.
    Feldmann, Marc
    NATURE REVIEWS RHEUMATOLOGY, 2009, 5 (10) : 578 - 582
12345